test

More stories

The EMBARK Model of Psychedelic Therapy

In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework...

Live Coverage: FDA Advisory Committee Reviews MDMA-Assisted Therapy for PTSD

Today, the FDA’s Psychopharmacologic Drugs Advisory Committee (PDAC) convenes to discuss Lykos Therapeutics’ MDMA-assisted therapy for PTSD New Drug Application (NDA).The meeting, which is...

ICER Panel Rejects MDMA-Assisted Therapy, Highlights Evidence Gaps and Study Flaws in 14-1 Vote

Yesterday, ICER’s independent appraisal committee, the New England Comparative Effectiveness Public Advisory Council (NE-CEPAC) met to discuss the effectiveness and value of Lykos Therapeutics’...

How Psychedelics Became Key to My Long COVID Recovery

How did psychedelics become key to one woman's recovery from long COVID? The post How Psychedelics Became Key to My Long COVID Recovery appeared first...

Long COVID and Psychedelics

In this episode, special guest host Court Wing interviews Monica Verduzco-Gutierrez, MD: professor and chair of rehabilitation medicine at UT Health San Antonio; Joel...

The Hidden History of Psychedelics in Australia

Learn all about the hidden history of psychedelics in Australia. The post The Hidden History of Psychedelics in Australia appeared first on Psychedelics Today.

Patients, Practitioners, Researchers and Public Submit Comments Ahead of FDA Advisory Committee on MDMA

Live Coverage Announcement: We will be covering next Tuesday’s Advisory Committee meeting live on Psychedelic Alpha. Join our newsletter to receive the link on...

Embracing the Mystery: Making Psychedelic Literature Engaging

In this episode, Joe interviews Sean Lawlor: writer and therapist specializing in ketamine-assisted therapy at Reflective Healing in Fort Collins, CO. His first book,...

What to Expect: FDA Advisory Committee Set to Review MDMA-Assisted Therapy for PTSD

In two weeks’ time, the FDA’s Psychopharmacologic Drugs Advisory Committee (PDAC) will meet to discuss Lykos Therapeutics’ MDMA-assisted therapy for PTSD New Drug Application...

The Economics of Psychedelics

In this episode, Joe interviews Elliot Marseille, DrPH, MPP: founding director of UC Berkeley’s Collaborative for the Economics of Psychedelics (CEP), a network of...

Pα+ Psychedelic Patent Analysis: April 2024

We added 16 PCTs and 26 U.S. patent applications focused on psychedelics to our tracker in the month of April 2024. New entries came...

Breaking Through Bureaucracy: Can D.C. Embrace Evidence-Based Drug Policy?

In this episode, Joe interviews two members of The Daschle Group: Founder and CEO, Senator Tom Daschle; and Public Policy Advisor, Charlie Panfil. As...

Most popular